INCOME TAX (Tables)

12 Months Ended

Jun. 30, 2021

Dec. 31, 2020

Schedule of income tax provision

	2020		2019
Statutory U.S. federal rate	$	(6,649,878)	$	(3,878,443)
State income tax net of federal benefit		(1,141,758)		(767,428)
Permanent items		77,747		109,580
Other prior year adjustments		(99,275)		(1,339)
Rate adjustment		(12,921)		65,267
Valuation allowance		7,826,085		4,472,363
Total income tax expense (benefit)	$	—	$	—

Summary of significant components of the Company's deferred tax assets

	2020		2019
Net operating loss carryforwards	$	24,923,945	$	18,039,466
Amortizable assets		6,321		7,143
Equity compensation		50,118		77,916
Salaries and wages		1,048,104		151,442
Deferred rent		—		133,387
Deferred revenue		861,120		544,415
Leasehold improvements		611,657		—
Other		303,317		26,535
Total deferred tax assets		27,804,582		18,980,304
Less: valuation allowance		(25,316,127)		(17,490,042)
Net deferred tax asset		2,488,455		1,490,262
Operating lease ROU		(545,045)		—
Fixed assets		(1,943,410)		(1,490,262)
Total deferred tax liabilities		(2,488,455)		(1,490,262)
Net deferred tax assets (liabilities)	$	—	$	—

LifeSci Acquisition II Corp

Schedule of income tax provision

	June 30,
	2021		2020
Federal
Current	$	—	$	—
Deferred		(117,904)		(210)
State
Current	$	—	$	—
Deferred		—		—
Change in valuation allowance		117,904		210
Income tax provision	$	—	$	—

Schedule of reconciliation of the total income tax provision tax rate to the statutory federal income tax rate

	June 30,
	2021		2020
Statutory federal income tax rate	21.0	%	21.0	%
State taxes, net of federal tax benefit	0.0	%	0.0	%
Change in valuation allowance	(21.0)	%	(21.0)	%
Income tax provision	0.0	%	0.0	%

Summary of significant components of the Company's deferred tax assets

	June 30,
	2021		2020
Deferred tax asset
Net operating loss carryforward	$	6,802	$	210
Startup/Organization Expenses		111,312		—
Total deferred tax asset		118,114		210
Valuation allowance		(118,114)		(210)
Deferred tax asset, net of allowance	$	—	$	—